Feb 4, 2026
•
14 min read
Why Prescription Drugs Dominate America’s Biggest Commercial Break
Jan 28, 2026
10 min read
Mark Cuban's face-off with Optum's CEO was really about who healthcare is actually for.
Jan 21, 2026
Take a peek under the hood with me...
Jan 14, 2026
12 min read
Pharmacists were trained to practice medicine. The system needs to let them.
Jan 7, 2026
A Wall Street Journal investigation reveals how insurers and PBMs oversupplied seniors with billions in unnecessary drugs — and billed taxpayers for the privilege.
Dec 17, 2025
An unapproved drug is being injected into Americans — and it needs to be shut down immediately
Dec 10, 2025
9 min read
A pharmaceutical giant just did what Washington won’t: challenge the PBM system at its foundation.
Dec 3, 2025
A pharmacist finds out who really pays for MFN pricing...
Nov 26, 2025
15 min read
A glitch in the system? Nope. The system working exactly as designed.
Nov 19, 2025
ERISA lawsuits are coming...
Nov 12, 2025
How PBMs Evolved to Sell Drugs to Themselves.
Nov 5, 2025
11 min read
My instant reaction to the TrumpRx GLP-1 rumors...
Oct 29, 2025
And for that reason... I'm in.
Oct 22, 2025
Your favorite creator might be the most persuasive drug rep in America.
Oct 15, 2025
When a pharmacy closes, its prescriptions don’t disappear. They get absorbed by the same companies that helped kill it.
Oct 8, 2025
Allow me to reintroduce myself...
Oct 1, 2025
Breaking down the TrumpRx announcement...
Sep 24, 2025
Correlation ≠ Causation
Sep 17, 2025
An explainer on beta-blockers.
Sep 10, 2025
My take on the newly released MAHA roadmap.
Sep 3, 2025
A pharmacist's rant on MAHA and the COVID vax.
Aug 27, 2025
8 min read
A taste of what happens when oversight weakens.
Aug 20, 2025
Consolidation disguised as access.
Aug 13, 2025
Eli Lilly’s “disappointment” might be the biggest GLP-1 story of the year.
Aug 6, 2025
The Price of Progress
